Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WSB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPS27A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RALGPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00939 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPG20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSPH4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUCKS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL4I1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTRK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EBAG9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHROOM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on